Skip to main content
Clinical Trials/NCT03819062
NCT03819062
Recruiting
Not Applicable

Sacral Neuromodulation as Treatment for Chronic Constipation

McMaster University1 site in 1 country20 target enrollmentSeptember 8, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Constipation
Sponsor
McMaster University
Enrollment
20
Locations
1
Primary Endpoint
Change in number of bowel movements/week
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to study if low level laser therapy will do more good than harm for patients with severe chronic refractory constipation. It is a proof of concept study without a placebo arm.

Detailed Description

Patients will be offered the therapy if High-Resolution Colonic Manometry has shown that coordination between colon motility and recto-anal activity is abnormal and that autonomic nervous system assessment suggests a dysfunction of communication between the spinal cord autonomic nerves and the colon-rectum-anus. The therapy consists of a 3 week treatment with a total of 8 sessions of low level laser therapy. Effects will be assessed using symptom and quality of life questionnaires and physiological assessments of colon and pelvic floor function, at 4 weeks and 12 weeks.

Registry
clinicaltrials.gov
Start Date
September 8, 2019
End Date
February 1, 2027
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jihong Chen

Assistant Professor

McMaster University

Eligibility Criteria

Inclusion Criteria

  • Patients with severe chronic refractory constipation
  • Must have undergone high resolution colonic manometry that shows abnormal coordination between colonic motility and ano-rectal function.

Exclusion Criteria

  • Pregnant patients
  • Known malignancies in the area of treatment
  • Active bleeding in area of treatment
  • Active deep vein thrombosis
  • When tatoos are present at area of treatment
  • Patients that are light sensitive
  • Patients who take NSAIDS or steroids.

Outcomes

Primary Outcomes

Change in number of bowel movements/week

Time Frame: 12 weeks

(significance level P\<0.05 comparing before and after).

Secondary Outcomes

  • Anal spincter pressure(4 weeks)
  • Change in quality of life assessed by questionnaire PAC-QOL(12 weeks)
  • Change in symptoms using the questionnaire PAC-SYM(12 weeks)
  • Autonomic function assessment(4 weeks)
  • Change in anal sphincter pressure due to attempting defecation(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials